From: Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients
Feature | HIV+/TB+ | HIV+/TB- | HIV-/TB- |
---|---|---|---|
Number | 19 | 20 | 20 |
Males | 12 | 14 | 15 |
Age, years | 28.4 ± 6.8 | 26.5±4.6 | 25.7 ± 3.6 |
Range | 19–48 | 22–37 | 21–44 |
Clinical signs suggesting TB (fever, weight loss, etc) | 18 | 0 | 0 |
Radiological abnormality (Chest x-ray/ CT defect) | 15 | 0 | 0 |
Disseminated TB | 6 | 0 | 0 |
Mean CD4 count, /mm3* | 116 ± 36.6 | 162.4 ± 24.2 | |
Range | 14–456 | 48–440 |